Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board
Zoetis, an animal health company spun off from Pfizer in 2013, is taking a representative from Bill Ackman's hedge fund Pershing Square Capital Management onto its board of directors...
Related Articles
- Family Dollar Sees 'Virtual Certainty' Of Antitrust Clearance For Dollar Tree Merger also written by Antoine Gara
- DuPont Spinoff Fans Flames In Trian Management's Scorched Earth Fight also written by Antoine Gara
- PepsiCo Puts Trian Business Advisor On Board also categorized in BoardMoves
- Warren Buffett And CalSTRS Agree On Brian Moynihan's Performance At Bank Of America also written by Antoine Gara
- Pandora Jewelry Names New CEO and Board Chairman also categorized in BoardMoves
- Amazon's Board Diversity Push Could Destroy Traditional Retail also categorized in BoardMoves
- Target CEO Gregg Steinhafel Resigns In Data Breach Fallout also categorized in BoardMoves
- Corporate Boards: Shifting From Aging Men To New Generation Of Women? also published in forbes.com
- Honest Company Diversifies Its Leadership With A Second Female Board Member also categorized in BoardMoves
- Airbnb Adds Outgoing American Express CEO Kenneth Chenault To Board of Directors also categorized in BoardMoves
Login to comment.